Pharmaceuticals are a critical input for the health sector. At the same time, the drug business sustains many individual and corporate livelihoods and produces handsome returns for those involved in the trade. Good governance is critical for the sector to maximize returns for public health and minimize risks for patients from ineffective or contaminated drugs. Given the large financial volume of the market, the potential for corruption is significant...
انظر المزيد
تفاصيل
-
2010/1/01
-
ورقة عمل
-
53074
-
1
-
1
-
2010/7/01
-
Disclosed
-
Assessment of governance and corruption in the pharmaceutical sector : lessons learned from low and middle income countries
-
millennium development goal